Details of the Drug

General Information of Drug (ID: DMR1455)

Drug Name

MEDI5395

Indication

Disease Entry	ICD 11	Status	REF
Solid tumour/cancer	2A00-2F9Z	Phase 1	[1]
------------------------------------------------------------------------------------

Drug Type

Oncolytic virus therapy

Cross-matching ID

References

1	ClinicalTrials.gov (NCT03889275) A Study of MEDI5395 in Combination With Durvalumab in Subjects With Select Advanced Solid Tumors. U.S. National Institutes of Health.